}

FDA authorizes Ebola fingerstick test

11/15/2018

The FDA announced that an emergency use authorization (EUA) has been issued for a rapid, single-use test for the detection of Ebola virus (Zaire ebolavirus). The DPP Ebola Antigen System is the second Ebola rapid antigen fingerstick test available under EUA, but the first that uses a portable battery-operated reader, which can help provide clear diagnostic results outside of laboratories and in areas where patients are likely to be treated. The EUA authority allows the agency to authorize the use of an unapproved medical product when there are no adequate, approved and available alternatives. Read the FDA news release.

<< return to Advocacy Updates